Nomura Holdings
NWBO

Nomura Holdings’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Nomura Holdings’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,400
Closed -$71K – 3376
2014
Q2 		$71K Buy
+10,400
New +$66.2K ﹤0.01% 2576
2013
Q4 		– Sell
-33,100
Closed -$111K – 2673
2013
Q3 		$111K Buy
33,100
+3,000
+10% +$10.4K ﹤0.01% 2049
2013
Q2 		$100K Buy
+30,100
New +$109K ﹤0.01% 1995

Other funds holding NWBO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's NWBO Position: Q3 2014 in Review

Nomura Holdings sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2014, closing a stake of 10,400 shares — an estimated $71K sold.

Nomura Holdings first reported a position in NWBO in Q2 2013 and held it in 3 quarters. The position peaked at $111K in Q3 2013. 71 funds tracked by Wall St. Rank hold NWBO as of Q3 2014.

  • Nomura Holdings reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2014 after selling out during the quarter.
  • Nomura Holdings sold 10,400 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2014, an estimated $71K.
  • Nomura Holdings first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 3 quarters.
  • Nomura Holdings's Northwest Biotherapeutics, Inc. Common stock position peaked at $111K in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2014.

Based on Nomura Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.